Pharmaco-epidemiological Study Describing a Population of Hypertensive Patients Treated With a Fixed-dose Combination of Telmisartan and Hydrochlorothiazide

Boehringer Ingelheim

Status: Completed

Conditions: Hypertension

Treatments: Drug: Telmisartan and hydrochlorothiazide

Study type: Observational

Funder types: Industry

Identifiers

NCT02248129

502.508

Details and patient eligibility

About

Study to compare the level of blood pressure control in hypertensive, hypertensive diabetics and hypertensive with renal insufficiency (observed data) in the study population, with the objectives of the High Authority for Health recommendations (benchmark)

Enrollment: 4,255 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Hypertensive patients already treated for at least 1 month with Telmisartan plus hydrochlorothiazide, consulting the physician consecutively for whatever reason

Exclusion criteria

• NA

Trial design

4,255 participants in 1 patient group

Hypertensive patients

Treatment:

Drug: Telmisartan and hydrochlorothiazide